Venture Life Group - VLG Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 42.44
▲ +0.44 (1.05%)

This chart shows the closing price for VLG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Venture Life Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VLG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VLG

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Venture Life Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 42.44.

This chart shows the closing price for VLG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Venture Life Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/8/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/7/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/6/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/15/2018Northland SecuritiesReiterated RatingBuy
9/20/2018Northland SecuritiesReiterated RatingBuy
8/16/2018Northland SecuritiesReiterated RatingBuy
8/2/2018Northland SecuritiesReiterated RatingBuy
7/20/2018Northland SecuritiesReiterated RatingBuy
6/18/2018Northern Trust Capital MarketsReiterated RatingBuyGBX 100
6/18/2018Northland SecuritiesReiterated RatingBuy
6/4/2018Northland SecuritiesReiterated RatingBuy
5/21/2018Northland SecuritiesReiterated RatingBuy
5/9/2018Northland SecuritiesReiterated RatingBuyGBX 100
3/22/2018Northland SecuritiesBoost TargetBuyGBX 94 ➝ GBX 100
2/20/2018Northland SecuritiesReiterated RatingBuyGBX 94
2/13/2018Northland SecuritiesReiterated RatingBuyGBX 94
(Data available from 2/7/2018 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/11/2022
  • 5 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/10/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/9/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/9/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/8/2022
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/8/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/7/2023
  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/6/2023

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Venture Life Group logo
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Read More

Today's Range

Now: GBX 42.44
Low: 41.60
High: 43

50 Day Range

MA: GBX 36.43
Low: 26.50
High: 43.98

52 Week Range

Now: GBX 42.44
Low: 23
High: 51

Volume

25,161 shs

Average Volume

270,777 shs

Market Capitalization

£53.69 million

P/E Ratio

2,122.00

Dividend Yield

0.09%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Venture Life Group?

The following Wall Street analysts have issued stock ratings on Venture Life Group in the last year:
View the latest analyst ratings for VLG.

What is the current price target for Venture Life Group?

0 Wall Street analysts have set twelve-month price targets for Venture Life Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Venture Life Group in the next year.
View the latest price targets for VLG.

What is the current consensus analyst rating for Venture Life Group?

Venture Life Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VLG.

What other companies compete with Venture Life Group?

How do I contact Venture Life Group's investor relations team?

Venture Life Group's physical mailing address is Venture House 2 Arlington Square, Downshire Way, BRACKNELL, RG12 1WA, United Kingdom. The company's listed phone number is +44-1344-742870. The official website for Venture Life Group is www.venture-life.com. Learn More about contacing Venture Life Group investor relations.